|
||
ARTICLE |
CORRESPONDENCE Yufang Shi: shiyu{at}umdnj.edu OR Gobardhan Das: dasgo{at}umdnj.edu
|
|
|---|
MHC class Iarestricted CD8+ T cells are the classic effector cells involved in cytotoxicity during adaptive immune responses. In addition to MHC class Ia, the mammalian genome encodes proteins with homology to the
chain of MHC class Ia molecules, which are often referred to as MHC class Ilike molecules. These proteins are involved in the selection and maintenance of innate-like lymphocytes (ILLs), including NKT cells and MHC class Ib restricted CD8+ T cells, which exhibit an activated memory phenotype and are thought to have critical immunomodulatory functions (15). By using genetically modified mice, recent studies have shown that NKT cells, restricted by the MHC class Ilike molecule CD1d, play a central role in the pathogenesis of Th2 celldriven immune disorders such as ulcerative colitis (6) and asthma (7). Importantly, NKT cells rapidly produce large amounts of IL-4 and IL-13 upon activation.
CD8+ T cells restricted by MHC class Ib molecules have an activated phenotype (8) and promptly produce cytokines upon activation (2), which are typical characteristics of ILLs. These cells also have a variety of immune regulatory functions, such as suppressing the activity of CD4+ T cells (9, 10), promoting differentiation of Th1 cells (2), and up-regulating immunity to infections (1114) and tumors (15). Thus, like NKT cells, these MHC class Ibrestricted CD8+ T cells have the characteristics of ILLs. These cells may serve as a bridge between innate and adaptive immunity, especially in helping the differentiation of Th1 cells by producing IFN-
at the early stage of an immune response. Because CD8+ ILLs exhibit an activated phenotype immediately after their maturation in the thymus (8), these cells are likely primed by and specific to self-antigens, suggesting that these cells might play a role in the pathogenesis of autoimmunity. Under normal physiological conditions, the number of ILLs is limited, and these cells are relatively inert, probably because the activity of these cells is controlled by regulatory mechanisms. We therefore hypothesized that, upon release from immune regulation, ILLs can initiate inflammation and autoimmunity. This possibility is supported by earlier studies, which showed that MHC class IIdeficient mice exhibit autoimmune-like syndromes (16, 17). The pathogenesis of autoimmunity in these animals is likely initiated by MHC class Irestricted T cells that are normally suppressed by CD4+ T cells. The identity of the CD8+ T cells that cause inflammation in these MHC class II deficient mice is unclear.
Experiments regarding the immunological functions of ILLs have been hampered by the lack of specific markers for these cells. To circumvent this problem, we have used a genetic approach to generate mice that exclusively express MHC class Ilike molecules. However, generating mice that are deficient in Kb, Db, and IAb genes (C57BL/6 mice do not express IE and L molecules) cannot be easily accomplished, because these genes are clustered on the H-2 locus of chromosome 17. We therefore used CIITA/ mice, which fail to express MHC class II molecules and produce few mature CD4+ T cells (18), except for CD1d-restricted CD4+ NKT cells. Thus, we crossed Kb/Db/ with CIITA/ mice to generate mice lacking both MHC class II and Ia molecules (Kb/Db/CIITA/), so that they only express MHC class Ilike molecules. To ensure that the T cells that developed in Kb/Db/CIITA/ mice are indeed restricted by MHC class Ilike molecules, we also generated ß2m/ CIITA/ mice, which are devoid of all MHC class I, class I like, and class II molecules. We found that Kb/Db/ CIITA/ mice, but not ß2m/CIITA/ mice, exhibited lymphoproliferative disease with an abnormal expansion of activated CD8+ T cells, spontaneous inflammatory bowel disease (IBD), and insulitis. Adoptive transfer of CD8+ T cells from Kb/Db/CIITA/ mice to syngeneic RAG/ pfn/ mice induced intestinal inflammation and insulitis. Furthermore, depletion of CD8+ T cells from Kb/Db/ CIITA/ mice failed to show symptoms of IBD or insulitis, suggesting that T cells selected by MHC class Ilike molecules are self-reactive, pathogenic, and capable of initiating and sustaining autoimmune inflammation.
| RESULTS |
|---|
|
|
|---|
|
|
Kb/Db/CIITA/ mice exhibit lymphoproliferative disease
Lymphoid organs such as spleens and lymph nodes of Kb/ Db/CIITA/ mice were dramatically enlarged, although thymi were normal in size (unpublished data). We found that Kb/Db/CIITA/ mice produced few CD4+ T cells but a large number of CD8+ T cells in their spleens. In contrast, ß2m/CIITA/ mice had virtually no mature CD4+ or CD8+ T cells (Fig. 3, a and b).
Because T cells are required for most autoimmune disorders, we analyzed T cell subsets in the spleens of Kb/Db/CIITA/ mice. The numbers of CD44hiCD8+ T cells were dramatically increased, whereas CD8+ T cells with a naive phenotype were virtually absent (Fig. 3 b). As MHC class II molecules are absent in these mice, we determined the phenotype of the few CD4+ T cells in Kb/Db/CIITA/ mice. Staining with anti-DX5, a marker for NK and NKT cells, suggested that most CD4+ cells in Kb/Db/CIITA/ mice are NKT cells (Fig. 3 c). Therefore, Kb/Db/ CIITA/ mice lack mature MHC class IIrestricted CD4+ T cells. Collectively, these data suggest that the large number of CD8+ T cells in Kb/Db/CIITA/ mice are selected and maintained by MHC class Ilike molecules.
|
|
Cytokines and chemokines produced by CD8+ T cells of Kb/Db/CIITA/ mice
To investigate cytokine and chemokine production by CD8+ T cells in Kb/Db/CIITA/ mice, we activated sorted CD8+ T cells from B6, Kb/Db/, and Kb/Db/ CIITA/ mice with plate-bound anti-CD3 and anti-CD28 antibodies. We found a considerable increase in IFN-
, TNF-
, IL-17, macrophage inflammatory protein 1
and 1ß, and RANTES for CD8+ T cells from Kb/Db/ CIITA/ mice (Fig. 4 e) but no change in IL-4, IL-6, and IL-10 (unpublished data). Interestingly, although the levels of inflammatory cytokines produced by CD8+ T cells isolated from Kb/Db/ mice are higher than C57BL/6 mice, they remain substantially lower than Kb/Db/CIITA/ mice. It is possible that the CD8+ T cells in Kb/Db/ mice are regulated by CD4+ T cells and that their activation potential is influenced by the presence of CD4+ T cells. Supplementation of IL-2 to the culture medium did not change the cytokine production pattern of CD8+ T cells from Kb/Db/ mice. This observation suggests that abrogation of acquired tolerance in CD8+ T cells of Kb/Db/ mice is independent of IL-2. The mechanisms controlling the tolerance of these pathogenic T cells are currently being investigated.
Surprisingly, we found that splenocytes from Kb/Db/ CIITA/ mice activated with anti-CD3 antibodies produced large amounts of IL-12 (unpublished data). T cells generally do not produce IL-12. However, it is conceivable that high levels of IFN-
, produced by the CD8+ T cells restricted by MHC class Ilike molecules, are responsible for activating IL-12producing cells such as macrophages. To test this hypothesis, we activated splenocytes with anti-CD3 overnight and performed intracellular staining of IL-12 in combination with surface marker staining. We found that CD11b+ cells, but not CD8+ T cells, showed strong intracellular IL-12 expression (Fig. S1, available at http://www.jem.org/cgi/content/full/jem.20060936/DC1). Neutralization of IFN-
with a specific antibody inhibited IL-12 production by CD11b+ cells. This is in agreement with our earlier study showing that anti-CD3induced IL-12 production in vivo is mediated by the early burst of IFN-
from CD8+ T cells restricted by MHC class Ilike molecules (2). These findings provide direct evidence that, in the absence of conventional T cells, CD8+ T lymphocytes restricted by MHC class Ilike molecules are pathogenic and sufficient to mediate autoimmune diseases. To determine whether the accumulation of peripheral CD8+ T cell is caused by clonal expansion, we tested the Vß usage of CD8+ T cells in Kb/Db/CIITA/ and corresponding wild-type mice. Although these cells expressed a variety of TCRß chains, we were unable to detect T cells expressing Vß9, Vß10, and Vß14. We observed a substantial increase in the usage of Vß2, Vß6, Vß8.1,2, and Vß13 (Table S2, available at http://www.jem.org/cgi/content/full/jem.20060936/DC1). Thus, CD8+ T cells restricted by MHC class Ilike molecules bear activated phenotypes, produce increased amounts of inflammatory cytokines, and have a biased Vß repertoire.
CD8+ T cells in Kb/Db/CIITA/ mice are pathogenic
To verify the role of CD8+ T cells in the pathological changes in Kb/Db/CIITA/ mice, we adoptively transferred CD8+ T cells from Kb/Db/CIITA/ mice to RAG/ pfn/ mice. Within 3 wk, recipient RAG/pfn/ mice developed intestinal and pancreatic inflammation (Fig. 5, a and b), whereas adoptive transfer of CD8+ T cells from normal mice did not induce such changes.
Furthermore, we depleted CD8+ T cells from Kb/Db/CIITA/ mice using monoclonal anti-CD8 antibodies (Fig. 5, c and d). These mice also failed to exhibit intestinal or pancreatic inflammation.
|
| DISCUSSION |
|---|
|
|
|---|
Breaking tolerance of CD8+ T cells restricted by MHC class Ilike molecules may represent a key step in the pathogenesis of autoimmune disorders. A previous report has established an etiological link between infection by gram-negative bacteria and autoimmune diseases (24). It is possible that, in mice or humans with genetic susceptibility to autoimmunity, microbial products can activate innate immune components that alter the immune tolerant status, thus allowing pathogenic CD8+ T cells restricted by MHC class I like molecules to expand and initiate autoimmune disease. In fact, a recent report showed that a Qa-1brestricted CD8+ T cell clone can kill macrophages that are stressed or infected with Salmonella (24). Interestingly, the killing of infected cells in this system was not guided by the harbored organism but depended on host stress proteins such as Hsp60. Furthermore, these authors showed that Qa-1 binds with an Hsp60-derived peptide, which can be recognized by a Qa-1brestricted CD8+ T cell clone (24). Interestingly, Qa-1b can also bind a peptide derived from preproinsulin and activate the same Qa-1brestricted CD8+ T cell clone that recognizes Hsp60. This finding suggests that self-peptides presented by Qa-1 can mediate the development of autoimmunity. Nevertheless, the contribution of Qa-1presented peptides to autoimmunity in our model system, in which all T cells are restricted by MHC class Ilike molecules, remains to be established.
CD8+ T cells restricted by MHC class Ilike molecules are selected and activated in the thymus. Under normal conditions, these cells are tolerant, but when tolerance is broken these T cells rapidly expand in the peripheral lymphoid organs and initiate autoimmune disease. Our results indicate that these CD8+ T cells are highly autoreactive. Furthermore, these cells are fully capable of initiating and propagating autoimmune diseases on their own. MHC class Ilike molecules are nonpolymorphic and bind to a limited set of self-antigens, resulting in a small population of selected T cells with limited diversity. As Kb/Db/CIITA/ mice do not bear conventional CD4+CD25+ or CD8+ T reg cells, their CD8+ T cells are not subject to T reg cellmediated tolerance and are free to initiate and propagate autoimmune diseases. Therefore, both MHC class IIrestricted CD4+ T cells and MHC class Iarestricted CD8+ T cells are required to suppress autoimmunity.
In summary, innate-like CD8+ T cells are primed and activated by self-antigens in the thymus and transported to the periphery, where they can expand exponentially and induce autoimmune diseases. These cells can induce inflammation in multiple organs. Therefore, innate-like CD8+ T cells may contribute to the generation of a variety of autoimmune diseases. These innate-like CD8+ T cells are restricted by MHC class Ilike molecules, which are nonpolymorphic in nature and thus present a limited set of self and/or foreign antigens to T cells. Uncontrolled reactivity of innate-like CD8+ T cells to self or foreign antigens may play a critical role in many autoimmune diseases.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Fluorochrome-conjugated antibodies against H-2Kb/Db (28-8-6), I-Ab (25-9-17), CD3 (145.2C11), TCR
ß (H-57), CD8
(53-6.7), CD4 (GK1.5), pan-NK marker CD49b (DX5), CD44 (IM7), ß7 integrin (M293), CD122 (TM-ß1), and Ly6C (AL-21); anti-IgG, anti-BrdUFITC, biotin-conjugated antiQa-1b (6A8.6F10.1A), and antiQa-2 (1-1-2); and purified anti-H2-M3 (H2-M3.130) antibodies were purchased from BD Biosciences. Anti-NKG2C FITC (20d5), anti-CD11bFITC, and antiIL-12PE (C17.8) for intracellular staining was purchased from eBioscience.
FACS staining and analysis.
Cells were harvested from the spleen, lymph nodes, thymus, or peripheral blood. Red blood cells were lysed by the ACK lysis buffer (Biosource International). Cells were suspended in staining buffer (PBS, 3% FCS, 0.01% Na-azide) at a concentration of 107 cells/ml. 100 µl of suspension was incubated either with directly conjugated antibodies or biotinylated antibodies for 30 min on ice. Streptavidin-PE was used as the secondary reagent with an additional incubation of 30 min on ice. Cells were washed twice with the staining buffer and fixed with 1% paraformaldehyde. Fluorescence intensity was measured by flow cytometry on a flow cytometer (FACStar; BD Immunocytometry).
T cell adoptive transfer.
CD4+ or CD8+ T cells from OT-II or OT-I TCR Tg mice and from Kb/Db/CIITA/ mice, respectively, were purified using Dynal Beads (Dynal), according to the supplier's instructions. For T cell survival experiments, cells were stained with CFSE, and 2 x 106 cells were injected into syngeneic RAG-2/ or Kb/Db/CIITA/ triple knockout mice. After 7 d, cells from spleen and lymph nodes were harvested, and the presence of CFSE-labeled cells was estimated on a flow cytometer. RAG-2/pfn/ mice were also adoptively transferred with CD8+ T cells isolated from Kb/Db/CIITA/ mice and analyzed for the development of autoimmunity.
T cell activation and cytokine detection.
Purified CD8 T cells from different strains of mice were activated with plate-bound anti-CD3 and anti-CD28 antibodies for 16 h. Cytokine and chemokine levels in culture supernatants were determined by multiplexed bead array immunoassay using Luminex Technology (Bio-Plex; Bio-Rad Laboratories). Unpurified splenocytes were activated with anti-CD3 antibodies for 18 h to examine IL-12 production. IL-12 was assayed by intracellular staining after treatment with 10 µg/ml brefeldin A during the last 6 h of culture. Cells were stained for surface markers, fixed with 1% paraformaldehyde for 30 min, washed, and resuspended in a permeabilization buffer provided in the Cytofix/Cytoperm kit (BD Biosciences), then stained with PE-conjugated rat antimurine IL-12. Stained cells were then analyzed by flow cytometry on a cytometer (FACScan; Becton Dickinson).
In vivo T cell proliferation assay by BrdU.
Mice were treated with BrdU in drinking water at 0.8 mg/ml (Sigma-Aldrich) for 9 d for assessing in vivo cell proliferation. Spleen and thymus were harvested, and single-cell suspensions were made. Cells were stained for surface markers using appropriate antibodies and fluorochromes. After washing, cells were resuspended in 0.15 M NaCl and fixed by gradual addition of ice-cold 95% ethanol. Cells were washed and incubated with 1% paraformaldehyde for 30 min at room temperature. Cells were stained with anti-BrdUFITC in the presence of DNase I. Samples were analyzed using a FACScan flow cytometer.
Gross examination of mice and histology.
Photographs of spleens, lymph nodes, or open abdominal cavities from 12-wk-old mice were taken using a digital camera (DSC V-3; Sony). For histology, pieces of intestine and pancreas were washed thoroughly in PBS and fixed in periodate-lysine-paraformaldehyde. Tissues were embedded in paraffin, and 5- to 6-µm sections were cut. Sections were stained with hematoxylin and eosin (H&E) and examined microscopically.
Online supplemental material.
Fig. S1 shows the importance of IFN-
in anti-CD3induced IL-12 production in splenocytes of Kb/Db/ CIITA/ mice. Table S1 demonstrates thymocyte phenotypes in different strains of mice. Table S2 reveals TCR Vß usage in CD8+ T cells of different strains of mice. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20060936/DC1.
| Acknowledgments |
|---|
This work was supported in part by United States Public Health Service grants (AI43384 and AI50222), a National Space Biomedical Research Institute grant (IIH00208), which is supported by the National Aeronautics and Space Administration through Cooperative Agreement NCC 9-58, and the University Professor Fund of the University of Medicine and Dentistry of New Jersey (to Y.F. Shi).
The authors have no conflicting financial interests.
Submitted: 2 May 2006
Accepted: 5 October 2006
| REFERENCES |
|---|
|
|
|---|
1 Bach, J.F., A. Bendelac, M.B. Brenner, H. Cantor, G. De Libero, M. Kronenberg, L.L. Lanier, D.H. Raulet, M.J. Shlomchik, and M.G. von Herrath. 2004. The role of innate immunity in autoimmunity. J. Exp. Med. 200:15271531.
2 Das, G., S. Sheridan, and C.A. Janeway Jr. 2001. The source of early IFN-gamma that plays a role in Th1 priming. J. Immunol. 167: 2004 2010.
3 Natarajan, K., H. Li, R.A. Mariuzza, and D.H. Margulies. 1999. MHC class I molecules, structure and function. Rev. Immunogenet. 1:3246.[Medline]
4 Soloski, M.J., and E.S. Metcalf. 2001. The involvement of class Ib molecules in the host response to infection with Salmonella and its relevance to autoimmunity. Microbes Infect. 3:12491259.[CrossRef][Medline]
5 Taniguchi, M., and T. Nakayama. 2000. Recognition and function of Valpha14 NKT cells. Semin. Immunol. 12:543550.[CrossRef][Medline]
6 Heller, F., I.J. Fuss, E.E. Nieuwenhuis, R.S. Blumberg, and W. Strober. 2002. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 17:629638.[CrossRef][Medline]
7 Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M.J. Grusby, R.H. DeKruyff, and D.T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9:582588.[CrossRef][Medline]
8 Urdahl, K.B., J.C. Sun, and M.J. Bevan. 2002. Positive selection of MHC class Ib-restricted CD8(+) T cells on hematopoietic cells. Nat. Immunol. 3:772779.[Medline]
9 Hu, D., K. Ikizawa, L. Lu, M.E. Sanchirico, M.L. Shinohara, and H. Cantor. 2004. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 5:516523.[CrossRef][Medline]
10 Jiang, H., and L. Chess. 2000. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Annu. Rev. Immunol. 18:185216.[CrossRef][Medline]
11 Bouwer, H.G., A. Bai, J. Forman, S.H. Gregory, E.J. Wing, R.A. Barry, and D.J. Hinrichs. 1998. Listeria monocytogenes-infected hepatocytes are targets of major histocompatibility complex class Ib-restricted antilisterial cytotoxic T lymphocytes. Infect. Immun. 66:28142817.
12 Lewinsohn, D.M., A.L. Briden, S.G. Reed, K.H. Grabstein, and M.R. Alderson. 2000. Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction. J. Immunol. 165:925930.
13 Lo, W.F., H. Ong, E.S. Metcalf, and M.J. Soloski. 1999. T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J. Immunol. 162:53985406.
14 Pamer, E.G., C.R. Wang, L. Flaherty, K.F. Lindahl, and M.J. Bevan. 1992. H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell. 70:215223.[CrossRef][Medline]
15 Chiang, E.Y., and I. Stroynowski. 2004. A nonclassical MHC class I molecule restricts CTL-mediated rejection of a syngeneic melanoma tumor. J. Immunol. 173:43944401.
16 Grusby, M.J., and L.H. Glimcher. 1995. Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 13:417435.[CrossRef][Medline]
17 Mombaerts, P., E. Mizoguchi, M.J. Grusby, L.H. Glimcher, A.K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:274282.[Medline]
18 Chang, C.H., S. Guerder, S.C. Hong, W. van Ewijk, and R.A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 4:167178.[CrossRef][Medline]
19 Hodgkinson, A.D., B.A. Millward, and A.G. Demaine. 2000. The HLA-E locus is associated with age at onset and susceptibility to type 1 diabetes mellitus. Hum. Immunol. 61:290295.[CrossRef][Medline]
20 Chun, T., C.J. Aldrich, M.E. Baldeon, L.V. Kawczynski, M.J. Soloski, and H.R. Gaskins. 1998. Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells. Immunology. 94:6471.[CrossRef][Medline]
21 Su, J., R.E. Berg, S. Murray, and J. Forman. 2005. Thymus-dependent memory phenotype CD8 T cells in naive B6.H-2Kb/Db/ animals mediate an antigen-specific response against Listeria monocytogenes. J. Immunol. 175:64506457.
22 Seaman, M.S., C.R. Wang, and J. Forman. 2000. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection. J. Immunol. 165:51925201.
23 Meresse, B., S.A. Curran, C. Ciszewski, G. Orbelyan, M. Setty, G. Bhagat, L. Lee, M. Tretiakova, C. Semrad, E. Kistner, et al. 2006. Reprogramming of CTLs into natural killerlike cells in celiac disease. J. Exp. Med. 203:13431355.
24 Lo, W.F., A.S. Woods, A. DeCloux, R.J. Cotter, E.S. Metcalf, and M.J. Soloski. 2000. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat. Med. 6:215218.[CrossRef][Medline]
25 Perarnau, B., M.F. Saron, B.R. San Martin, N. Bervas, H. Ong, M.J. Soloski, A.G. Smith, J.M. Ure, J.E. Gairin, and F.A. Lemonnier. 1999. Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 29:12431252.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|